# Enhanced Vision and Imaging Tests for Enabling Treatment Trials in Early and Intermediate AMD

> **NCT07515521** · — · RECRUITING · sponsor: **Maximilian Pfau** · enrollment: 150 (estimated)

## Conditions studied

- Age - Related Macular Degeneration (AMD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07515521
- **Lead sponsor:** Maximilian Pfau
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-15
- **Primary completion:** 2028-12-15
- **Final completion:** 2028-12-15
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07515521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07515521, "Enhanced Vision and Imaging Tests for Enabling Treatment Trials in Early and Intermediate AMD". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07515521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*